Publication | Closed Access
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective
18
Citations
38
References
2016
Year
ThrombosisVenous ThrombosisCardiovascular DiseaseStrokePatient SafetyPharmacotherapyCost EffectivenessCoagulopathyAtrial FibrillationPublic HealthPlatelet AntagonistMedicineAnticoagulantAtherosclerosisApixaban Versus WarfarinAnesthesiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1